<DOC>
	<DOCNO>NCT00226902</DOCNO>
	<brief_summary>Dialysis patient suffer many problem blood vessel even patient add complication diabetes . Diabetics number reason vascular disease one new area research look cell line blood vessel , call endothelial cell . It think number red blood cell blood ( haemoglobin concentration ) affect function cell . There little information available haemoglobin level best dialysis patient . As diabetic account almost 40 % dialysis patient worldwide important understand effect different haemoglobin level blood vessel . Hypothesis : Endothelial cell function relate expansile capacity blood vessel affect different haemoglobin concentration [ Hb ] dialysis patient .</brief_summary>
	<brief_title>Vascular Reactivity Kidney Disease Patients</brief_title>
	<detailed_description>This project go ask dialysis patient ( diabetic non-diabetic ) undergo series test three different time point one year period : baseline set test , test haemoglobin maintain 130-140g/L repeat test haemoglobin maintain 105-115g/L . The current recommendation haemoglobin 110-120g/L . Patients require take study medication specialist kidney doctor , use usual medication iron erythropoietin therapy , change haemoglobin level .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>1 . Aged 1880 year 2 . Patients receive either conventional haemodialysis 34 x week , duration &gt; 6 month peritoneal dialysis duration &gt; 6 month 3 . Stable dialysis access least 3 month ( Permcath / PTFE / AVF ) 4 . On erythropoietin iron therapy , stable [ Hb ] x 2 month ( 105 135g/L ) 1 . Uncontrolled BP : requiring dry weight medication change within 4 week prior study 2 . Patients dysrhythmias 3 . Pre dialysis SBP &gt; 180 mmHg &gt; 2 time within 2 week period 4 . Between dialysis weight gain &gt; 5 % body weight ( evident &gt; 2 times/ 2 week period ) 5 . Soft tissue ulcer 6 . Non traumatic amputation 7 . Unstable cardiac function : ischaemic non ischaemic event require modification therapy , admission hospital within 3 month study start : accord clinical discretion 8 . Planned operative procedure within 6 month study start ( include Transplant , CABG , PTCA , vascular surgery ) 9 . Dementia 10 . Clinical inability comply test 11 . Malignancy ( active / treatment ) 12 . Known hyporesponsiveness ERT ( &gt; 200U/kg/wk ) 13 . Evidence chronic gastrointestinal bleeding 14 . Inadequate dialysis ( PRU &lt; 65 % KT/V &lt; 1.2 ) 15 . Participation investigational study within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Hemoglobin</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Vascular reactivity</keyword>
</DOC>